Skip to main content

EC 35 Pill - yellow capsule-shape

Pill with imprint EC 35 is Yellow, Capsule-shape and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Actavis.

Risedronate is used in the treatment of Prevention of Osteoporosis; Paget's Disease; Osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EC 35

Risedronate sodium delayed-release 35 mg EC 35

Risedronate Sodium Delayed-Release

EC 35
35 mg
Prescription only
Drug Class
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Inactive Ingredients
edetate disodium, ferric oxide yellow, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polysorbate 80, microcrystalline cellulose, silicon dioxide, sodium starch glycolate type A potato, stearic acid, magnesium silicate, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3876 (Discontinued) Watson Pharmaceuticals, Inc.
00430-0979 Warner Chilcott

Get help with Imprint Code FAQs.

Related images for "EC 35"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.